Literature DB >> 23430548

Subjective and Objective Assessment of Hand Function in Mucopolysaccharidosis IVa Patients.

Riffat Aslam1, Annelotte C M van Bommel2, Christian J Hendriksz3, Andrea Jester4.   

Abstract

INTRODUCTION: Morquio A is classically described as a skeletal dysplasia, but the impact of the abnormalities on the upper limb has not been described. AIM: The aim of our study is to assess the level of subjective and objective functions of the hand and upper limb in Morquio A patients in order to advance understanding as this may change future management for this complex group of patients.
METHOD: We have evaluated a series of ten patients with Morquio syndrome who are currently part of the enzyme replacement therapy trials in our unit. To establish functional levels, we developed a questionnaire based on the principles of the World Health Organization International Classification of Functioning, Disability and Health (WHO ICF). Furthermore, we measured patients' grip function and range of motion.
RESULTS: All patients showed hypermobility and limited control of the wrist. Their grip strength was reduced and they showed higher difficulty levels for activities involving strength. It is feasible that the wrist abnormalities may be the major cause of functional loss for Morquio patients.
CONCLUSION: Our findings suggest the wrist itself represents an area that we should focus on to be able to improve the patients' functional abilities and hence their level of independence on day-to-day basis.

Entities:  

Year:  2012        PMID: 23430548      PMCID: PMC3565635          DOI: 10.1007/8904_2012_179

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  11 in total

1.  Radiology of pediatric syndromes.

Authors:  R Lachman
Journal:  Curr Probl Pediatr       Date:  1979-02

2.  Carpal tunnel syndrome in the mucopolysaccharidoses and mucolipidoses.

Authors:  F S Haddad; D H Jones; A Vellodi; N Kane; M C Pitt
Journal:  J Bone Joint Surg Br       Date:  1997-07

3.  The mucopolysaccharidoses and related conditions.

Authors:  K D Eggli; J P Dorst
Journal:  Semin Roentgenol       Date:  1986-10       Impact factor: 0.800

4.  Grip and pinch strength: norms for 6- to 19-year-olds.

Authors:  V Mathiowetz; D M Wiemer; S M Federman
Journal:  Am J Occup Ther       Date:  1986-10

5.  Incidence of the mucopolysaccharidoses in Northern Ireland.

Authors:  J Nelson
Journal:  Hum Genet       Date:  1997-12       Impact factor: 4.132

6.  Enzyme-replacement therapy in mucopolysaccharidosis I.

Authors:  E D Kakkis; J Muenzer; G E Tiller; L Waber; J Belmont; M Passage; B Izykowski; J Phillips; R Doroshow; I Walot; R Hoft; E F Neufeld
Journal:  N Engl J Med       Date:  2001-01-18       Impact factor: 91.245

7.  Prevalence of lysosomal storage diseases in Portugal.

Authors:  Rui Pinto; Carla Caseiro; Manuela Lemos; Lurdes Lopes; Augusta Fontes; Helena Ribeiro; Eugénia Pinto; Elisabete Silva; Sónia Rocha; Ana Marcão; Isaura Ribeiro; Lúcia Lacerda; Gil Ribeiro; Olga Amaral; M C Sá Miranda
Journal:  Eur J Hum Genet       Date:  2004-02       Impact factor: 4.246

8.  Growth charts for patients affected with Morquio A disease.

Authors:  Adriana M Montaño; Shunji Tomatsu; Ana Brusius; Mary Smith; Tadao Orii
Journal:  Am J Med Genet A       Date:  2008-05-15       Impact factor: 2.802

9.  Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice.

Authors:  Melita Dvorak-Ewell; Dan Wendt; Chuck Hague; Terri Christianson; Vish Koppaka; Danielle Crippen; Emil Kakkis; Michel Vellard
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

10.  International Morquio A Registry: clinical manifestation and natural course of Morquio A disease.

Authors:  A M Montaño; S Tomatsu; G S Gottesman; M Smith; T Orii
Journal:  J Inherit Metab Dis       Date:  2007-03-08       Impact factor: 4.750

View more
  13 in total

1.  Molecular testing of 163 patients with Morquio A (Mucopolysaccharidosis IVA) identifies 39 novel GALNS mutations.

Authors:  A Morrone; K L Tylee; M Al-Sayed; A C Brusius-Facchin; A Caciotti; H J Church; M J Coll; K Davidson; M J Fietz; L Gort; M Hegde; F Kubaski; L Lacerda; F Laranjeira; S Leistner-Segal; S Mooney; S Pajares; L Pollard; I Ribeiro; R Y Wang; N Miller
Journal:  Mol Genet Metab       Date:  2014-03-20       Impact factor: 4.797

Review 2.  Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA.

Authors:  Hira Peracha; Kazuki Sawamoto; Lauren Averill; Heidi Kecskemethy; Mary Theroux; Mihir Thacker; Kyoko Nagao; Christian Pizarro; William Mackenzie; Hironori Kobayashi; Seiji Yamaguchi; Yasuyuki Suzuki; Kenji Orii; Tadao Orii; Toshiyuki Fukao; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2018-05-15       Impact factor: 4.797

Review 3.  International guidelines for the management and treatment of Morquio A syndrome.

Authors:  Christian J Hendriksz; Kenneth I Berger; Roberto Giugliani; Paul Harmatz; Christoph Kampmann; William G Mackenzie; Julian Raiman; Martha Solano Villarreal; Ravi Savarirayan
Journal:  Am J Med Genet A       Date:  2014-10-24       Impact factor: 2.802

4.  Overcoming the barriers to diagnosis of Morquio A syndrome.

Authors:  Kaustuv Bhattacharya; Shanti Balasubramaniam; Yew Sing Choy; Michael Fietz; Antony Fu; Dong Kyu Jin; Ok-Hwa Kim; Motomichi Kosuga; Young Hee Kwun; Anita Inwood; Hsiang-Yu Lin; Jim McGill; Nancy J Mendelsohn; Torayuki Okuyama; Hasri Samion; Adeline Tan; Akemi Tanaka; Verasak Thamkunanon; Teck-Hock Toh; Albert D Yang; Shuan-Pei Lin
Journal:  Orphanet J Rare Dis       Date:  2014-11-30       Impact factor: 4.123

5.  Clinical, biochemical and genetic profiles of patients with mucopolysaccharidosis type IVA (Morquio A syndrome) in Malaysia: the first national natural history cohort study.

Authors:  Huey Yin Leong; Nor Azimah Abdul Azize; Hui Bein Chew; Wee Teik Keng; Meow Keong Thong; Mohd Khairul Nizam Mohd Khalid; Liang Choo Hung; Norzila Mohamed Zainudin; Azura Ramlee; Muzhirah Aisha Md Haniffa; Yusnita Yakob; Lock Hock Ngu
Journal:  Orphanet J Rare Dis       Date:  2019-06-14       Impact factor: 4.123

6.  Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance.

Authors:  Mehmet Umut Akyol; Tord D Alden; Hernan Amartino; Jane Ashworth; Kumar Belani; Kenneth I Berger; Andrea Borgo; Elizabeth Braunlin; Yoshikatsu Eto; Jeffrey I Gold; Andrea Jester; Simon A Jones; Cengiz Karsli; William Mackenzie; Diane Ruschel Marinho; Andrew McFadyen; Jim McGill; John J Mitchell; Joseph Muenzer; Torayuki Okuyama; Paul J Orchard; Bob Stevens; Sophie Thomas; Robert Walker; Robert Wynn; Roberto Giugliani; Paul Harmatz; Christian Hendriksz; Maurizio Scarpa
Journal:  Orphanet J Rare Dis       Date:  2019-06-13       Impact factor: 4.123

7.  Orthopedic management of the extremities in patients with Morquio A syndrome.

Authors:  Klane K White; Andrea Jester; C Edward Bache; Paul R Harmatz; Renée Shediac; Mihir M Thacker; William G Mackenzie
Journal:  J Child Orthop       Date:  2014-07-08       Impact factor: 1.548

8.  Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study.

Authors:  Christian J Hendriksz; Barbara Burton; Thomas R Fleming; Paul Harmatz; Derralynn Hughes; Simon A Jones; Shuan-Pei Lin; Eugen Mengel; Maurizio Scarpa; Vassili Valayannopoulos; Roberto Giugliani; Peter Slasor; Debra Lounsbury; Wolfgang Dummer
Journal:  J Inherit Metab Dis       Date:  2014-05-09       Impact factor: 4.982

9.  Does orthopaedic surgery improve quality of life and function in patients with mucopolysaccharidoses?

Authors:  N Williams; D Challoumas; D M Eastwood
Journal:  J Child Orthop       Date:  2017-08-01       Impact factor: 1.548

Review 10.  Health-related quality of life in mucopolysaccharidosis: looking beyond biomedical issues.

Authors:  Christian J Hendriksz; Kenneth I Berger; Christina Lampe; Susanne G Kircher; Paul J Orchard; Rebecca Southall; Sarah Long; Stephen Sande; Jeffrey I Gold
Journal:  Orphanet J Rare Dis       Date:  2016-08-26       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.